{"id":16866,"date":"2021-01-05T01:25:38","date_gmt":"2021-01-04T22:25:38","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/2021\/01\/05\/evaluation-of-tigecycline-susceptibility-by-e-test-in-multidrug-resistant-acinetobacter-baumannii-isolates\/"},"modified":"2021-01-05T01:25:38","modified_gmt":"2021-01-04T22:25:38","slug":"evaluation-of-tigecycline-susceptibility-by-e-test-in-multidrug-resistant-acinetobacter-baumannii-isolates","status":"publish","type":"post","link":"https:\/\/www.klimikdergisi.org\/en\/2021\/01\/05\/evaluation-of-tigecycline-susceptibility-by-e-test-in-multidrug-resistant-acinetobacter-baumannii-isolates\/","title":{"rendered":"Evaluation of Tigecycline Susceptibility by E-Test\u00ae in Multidrug-Resistant Acinetobacter baumannii Isolates"},"content":{"rendered":"<h1>Abstract<\/h1>\n<p> <strong>Objective<\/strong>: Emergence of multidrug resistance among Acinetobacter spp. complicates treatment of serious infections due to these organisms. Tigecycline is a member of a new class of antimicrobials, the glycylcyclines.\u00a0<\/p>\n<p> <strong>Methods<\/strong>: In this study, we evaluated the in vitro activity of tigecycline in 121 multidrug resistant (MDR) A. baumannii isolates by E-test\u00ae (AB Biodisk, Sweden).\u00a0<\/p>\n<p> <strong>Results<\/strong>: Among these isolates, 96 (79%) were susceptible to tigecycline, 19 (16%) showed intermediate susceptibility and 6 (5%) were resistant. MIC50 and MIC90 were 1.5 and 4 \u00b5g\/ml, respectively. Seventy four per cent of carbapenem resistant isolates were found to be susceptible to tigecycline.\u00a0<\/p>\n<p> <strong>Conclusion<\/strong>: In conclusion, tigecycline may prove useful in treating infections due to MDR Acinetobacter species.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract Objective: Emergence of multidrug resistance among Acinetobacter spp. complicates treatment of serious infections due to these organisms. Tigecycline is a member of a new class of antimicrobials, the glycylcyclines.\u00a0 Methods: In this study, we evaluated the in vitro activity of tigecycline in 121 multidrug resistant (MDR) A. baumannii isolates by E-test\u00ae (AB Biodisk, Sweden).\u00a0 [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5130],"tags":[3903,3307,3905,3907],"class_list":["post-16866","post","type-post","status-publish","format-standard","hentry","category-original-article","tag-acinetobacter-baumannii","tag-etest","tag-multidrug-resistance","tag-tigecycline"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/16866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/comments?post=16866"}],"version-history":[{"count":0,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/16866\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/media?parent=16866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/categories?post=16866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/tags?post=16866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}